Norway vs Slovenia: Proportion of isolates with decreased susceptibility or resistance
Norway
0
in 2018
Slovenia
0
in 2018
Norway rank
15th
Slovenia rank
15th
Proportion of isolates with decreased susceptibility or resistance over time
- Norway
- Slovenia
How they compare
Norway currently reports 0 against 0 in Slovenia, a difference of 0.
The two have swapped places 2 times across 10 shared years of data; in 2009 it was Slovenia ahead.
Norway ranks 15th and Slovenia ranks 15th of 27 countries.
Slovenia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Norway | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.9091 | 8.33 | 7.42 | Slovenia |
| 2010s | 2.98 | 3.7 | 0.7267 | Slovenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Norway or Slovenia?
- Norway, at 0 against 0 in Slovenia as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Norway and Slovenia?
- 0, with Norway ahead.
- How many years of comparable data are there for Norway and Slovenia?
- 10 years are reported by both, from 2009 to 2018.
- How do Norway and Slovenia rank globally for proportion of isolates with decreased susceptibility or resistance?
- Norway ranks 15th and Slovenia ranks 15th of 27 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.